In 2014, the Task Force on Myocardial Revascularization of the European Society of Cardiology and the European Association for Cardio-Thoracic Surgery with the special contribution of the European Association of Percutaneous Cardiovascular Interventions published a comprehensive set of recommendations on myocardial revascularization in patients presenting with acute or chronic coronary artery disease. In the United States, pertinent guidance on this topic has been published by the American College of Cardiology, American Heart Association and other relevant societies in multiple guideline documents that have been published in recent years. This document brings together European and American recommendations on myocardial revascularization with a focus on the role of cardiac imaging ( European Association of Percutaneous Cardiovascular Interventions (EAPCI) published a comprehensive set of recommendations on myocardial revascularization in patients presenting with acute or chronic coronary artery disease (CAD). 1 In the United States, pertinent guidance on this topic has been published by the American College of Cardiology (ACC), American Heart Association (AHA), and other relevant societies in multiple guideline documents that have been published in recent years. [2] [3] [4] [5] [6] [7] [8] [9] [10] This document brings together European and American recommendations on myocardial revascularization for side-by-side comparison; class (I, II or III) and level of evidence (A, B or C) are shown for each recommendation (Tables 1, 2, 3, 4, 5, 6 and Figures 1, 2 ). This is followed by two Editorial comments that reflect on the similarities and the differences between European and American guidance and the relevance of these to clinical practice. This represents the second of a new series of comparative guidelines review; the first of these focused on the recently published ACC/AHA and ESC/ESA guidelines for the cardiovascular evaluation and management of patients undergoing non-cardiac surgery. [11] [12] [13] CABG is recommended to improve survival in patients with a) target vessels supplying a large area of viable myocardium; b) mild to moderate LV systolic dysfunction (LVEF, 35-50%) and significant multivessel CAD or proximal LAD stenosis when viable myocardium is present in the region of intended revascularization 5, 6 à ''Especially if a post-operative LV end-systolic volume index \70mL/m 2 can be predictably achieved'' 1 . ACC/AHA guidelines discuss surgical reverse remodeling or LV aneurysmectomy in isolation, with a IIb recommendation in carefully selected patients with HFrEF for specific indications, including intractable heart failure and ventricular arrhythmias 9 § ESC guidelines recommend CABG to improve prognosis in patients with severe LV dysfunction and significant LAD stenosis and multivessel CAD but do not specify the state of viability (class I, LOE B) 1 2 § Ischemia at low workload, early onset ischemia, multiple areas of high-grade wall motion abnormality, or reversible perfusion defect This recommendation is most appropriate in patients who can exercise adequately and have an interpretable ECG. CABG, coronary artery bypass grafting; CTA, computed tomographic angiography; PCI, percutaneous coronary intervention.
